FDA — authorised 12 July 2002
- Application: NDA021282
- Marketing authorisation holder: RB HLTH
- Local brand name: MUCINEX
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
🇺🇸 Guafenesin tablets in United States
FDA authorised Guafenesin tablets on 12 July 2002
Marketing authorisation
Other Respiratory approved in United States
Frequently asked questions
Is Guafenesin tablets approved in United States?
Yes. FDA authorised it on 12 July 2002.
Who is the marketing authorisation holder for Guafenesin tablets in United States?
RB HLTH holds the US marketing authorisation.